Riku Katainen
- Obstetrics and Gynecology top 1%
- Uterine Myomas and Treatments 4
- Reproductive Medicine top 1%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
-
- Genetic factors in colorectal cancer 11
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 5
-
- RNA modifications and cancer 5
- DNA Repair Mechanisms 3
-
- Genomics and Rare Diseases 3
- Chronic Lymphocytic Leukemia Research 3
Riku Katainen
32 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Obstetrics and Gynecology 558
- Reproductive Medicine 492
- Cancer Research 287
- Pathology and Forensic Medicine 301
- Oncology 280
Countries citing papers authored by Riku Katainen
This map shows the geographic impact of Riku Katainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riku Katainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riku Katainen more than expected).
Fields of papers citing papers by Riku Katainen
This network shows the impact of papers produced by Riku Katainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riku Katainen. The network helps show where Riku Katainen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Riku Katainen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2020 | 188 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 29 | |
| 7 | 2018 | 54 | |
| 8 | 2018 | 33 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 14 | |
| 11 | 2017 | 18 | |
| 12 | 2017 | 63 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 79 | |
| 15 | 2014 | 22 | |
| 16 | 2014 | 31 | |
| 17 | 2013 | 60 | |
| 18 | 2013 | 252 | |
| 19 | MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomasbreakdown → | 2011 | 470 |
| 20 | 2007 | 34 |
About Riku Katainen
Riku Katainen is a scholar working on Pathology and Forensic Medicine, Cancer Research and Obstetrics and Gynecology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (11 papers), Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Treatments and Studies (5 papers), RNA modifications and cancer (5 papers), Uterine Myomas and Treatments (4 papers), Genomics and Rare Diseases (3 papers), DNA Repair Mechanisms (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Obstetrics and Gynecology (558 citations), Reproductive Medicine (492 citations) and Cancer Research (287 citations). Riku Katainen has collaborated with scholars based in Finland, Sweden and Denmark. Frequent co-authors include Lauri A. Aaltonen, Eevi Kaasinen, Pia Vahteristo, Miika Mehine, Netta Mäkinen, Esa Pitkänen, Jari Sjöberg, Minna Taipale, Massimiliano Gentile and Jussi Taipale. Their work appears in journals such as PLoS Genetics, Genes Chromosomes and Cancer, Scientific Reports, British Journal of Cancer and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.